Dual Bronchodilators and β-Blockade for Cardiovascular Risk in Chronic Obstructive Pulmonary Disease

被引：1
作者：
Zaheen, Ahmad [1 ]
Anand, Anju [2 ]
Stanbrook, Matthew B. [3 ]
机构：
[1] Univ Toronto, Dept Respirol, Toronto, ON, Canada
[2] St Michaels Hosp, Div Respirol, Toronto, ON, Canada
[3] Toronto Western Hosp, Div Respirol, 399 Bathurst St,M5T2S8 East Wing,7th Floor, Toronto, ON M5T 2S8, Canada
来源：
JAMA INTERNAL MEDICINE | 2018年 / 178卷 / 05期
关键词：
D O I：
10.1001/jamainternmed.2018.1442
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：730 / +
页数：3
相关论文
共 4 条
  • [1] [Anonymous], MAN PREV COPD GLOB I
  • [2] Cardiovascular Safety of Inhaled Long-Acting Bronchodilators in Individuals With Chronic Obstructive Pulmonary Disease
    Gershon, Andrea
    Croxford, Ruth
    Calzavara, Andrew
    To, Teresa
    Stanbrook, Matthew B.
    Upshur, Ross
    Stukel, Therese A.
    [J]. JAMA INTERNAL MEDICINE, 2013, 173 (13) : 1175 - 1184
  • [3] Beta-blocker under-use in COPD patients
    Lim, Kuan Pin
    Loughrey, Sarah
    Musk, Michael
    Lavender, Melanie
    Wrobel, Jeremy P.
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 3041 - 3046
  • [4] Association of Cardiovascular Risk With Inhaled Long-Acting Bronchodilators in Patients With Chronic Obstructive Pulmonary Disease A Nested Case-Control Study
    Wang, Meng-Ting
    Liou, Jun-Ting
    Lin, Chen Wei
    Tsai, Chen-Liang
    Wang, Yun-Han
    Hsu, Yu-Juei
    Lai, Jyun-Heng
    [J]. JAMA INTERNAL MEDICINE, 2018, 178 (02) : 229 - 238
1